Monday 2 July 2018
Hypertension: New Developments in Understanding and Management
9:25 - 11:05
Organizers
• Professor David Webb, University of Edinburgh, UK
• Dr Neeraj (Bean) Dhaun, University of Edinburgh, UK
Chairs
• Dr Hiroshi Watanabe, Hamamatsu University School of Medicine, Japan
• Professor David Webb, University of Edinburgh, UK
Speakers
• Management of hypertension in chronic kidney disease
Dr Neeraj (Bean) Dhaun, University of Edinburgh, UK
• Poor adherence to anti-hypertensive treatment: The elephant in the room
Professor Una Martin, University of Birmingham, UK
• Prospects for novel therapeutic approaches to hypertension
Professor David Webb, University of Edinburgh, UK
• New evidence on optimal management of resistant hypertension
Professor Bryan Williams, University College London, UK
Health Technology Assessment (HTA) for Smaller Countries: The Central Role of Clinical Pharmacology
16:10 - 17:50
Organizers/Chairs
• Professor Phil Routledge, Cardiff University, UK
• Professor David Webb, University of Edinburgh, UK
Speakers
• Health Technology Assessment (HTA) for Smaller Countries: The role of the health economist
Professor Dyfrig Hughes, Bangor University, UK
• The role of the clinical pharmacologist
Professor David Webb, University of Edinburgh, UK
• The role of the pharmacist and access issues
Dr Karen Samuels , University Hospital Llandough, UK
• How this works effectively in practice
Professor Ken Paterson, University of Glasgow, UK
Tuesday 3 July 2018
Ca2+ Signaling in Health and Disease
9:25 - 11:05
Chairs
• Professor Gary Stephens, University of Reading, UK
• Professor Sumiko Mochita, Tokyo Medical University, Japan
Speakers
• Neuronal activity-dependent millisecond Ca2+ dynamics activate multiple protein cascades for synaptic vesicle control
Professor Sumiko Mochita, Tokyo Medical University, Japan
• Voltage gated calcium channels as molecular targets for pain therapeutics
Professor Gerald W. Zamponi, University of Calgary, Canada
• Functional Interaction between Ca22+-permeable TRP channels and Ca2+-activated chloride channel, anoctamin 1
Makoto Tominaga, Okazaki Institute for Integrative Bioscience, Japan
• The role of N-type calcium channels and their auxiliary subunits in pain pathways
Professor Annette C. Dolphin, University College London, UK
The BPS Focus on Pharmacology Project: Securing the Future of Pharmacology & Clinical Pharmacology
15:10 - 16:50
Organizers
• Professor David Webb, University of Edinburgh, UK
• Jonathan Bruun, British Pharmacological Society, UK
Chairs
• Professor Stephen J. Hill, University of Nottingham & President, British Pharmacological Society, UK
• Professor David Webb, University of Edinburgh, UK
Speakers
• The problem with Pharmacology: The need for audit and impact
Professor David Webb, University of Edinburgh, UK
• Developing research projects to demonstrate the value and impact of pharmacology and clinical pharmacology
Dr Anna Y. Zecharia, British Pharmacological Society, UK
• Methods for the development of curricula in pharmacology, the BPS experience
Dr Melisa ‘Lisa’ Wallace, Swansea University, UK; VP Academic Development
• British Pharmacological Society Results: The impact of the Focus on Pharmacology project, and its implications for the global pharmacology community
Professor Stephen J. Hill, University of Nottingham & President, British Pharmacological Society, UK
Friday 6 July 2018
Cutting Edge Assay Technologies for Studying Molecular and Cellular Pharmacology (Joint Symposium between BPS and ASCPT)
8:30 - 10:10
Organizers/Chairs
• Professor Kevin Pfleger, Harry Perkins Institute of Medical Research, Australia
• Dr Michelle L. Halls, Monash University, Australia
Speakers
• Cellular imaging technologies
Atsushi Miyawaki, RIKEN Brain Science Institute/ RIKEN Center for Advanced Photonics, Japan
• Understanding spatial and temporal control of GPCR signalling using fluorescence and bioluminescence
Dr Michelle L. Halls, Monash University, Australia
• Fluorescence and bioluminescence approaches to study ligand binding to GPCRs and RTKs
Professor Stephen J. Hill, University of Nottingham & President, British Pharmacological Society, UK
• Utilising BRET to decipher the complexities of cellular signalling
Dr Carl White, Harry Perkins Institute of Medical Research, Australia
New Perspective on the Function and Pharmacology of the Renin-angiotensin System
10:20 - 12:00
Organizer
• Professor Clare Stanford, University College London IRIS, UK
Chairs
• Professor Clare Stanford, University College London IRIS, UK
• Kouichi Tamura, Yokohama City University Graduate School of Medicine, Japan
Speakers
• Pleiotropic mechanisms and actions of the brain renin-angiotensin system
Dr Robert C. Speth, Nova Southeastern University, USA
• An emerging role of angiotensin receptor binding protein ATRAP as a possible novel player in pathophysiology of visceral obesity and metabolic disorders
Kouichi Tamura, Yokohama City University Graduate School of Medicine, Japan
• The neuronal renin-angiotensin system: A new strategy for PTSD and fear related disorders
Dr Paul J. Marvar, The George Washington University, USA
• Targeting the neuronal renin-angiotensin system in prevention of neurodegeneration and dementia
Professor Ursula Quitterer, University of Zurich, Switzerland
System Pharmacology of the AMPK-activated Protein Kinase
10:20 - 12:00
Organizers/Chairs
• Professor A. Mark Evans, University of Edinburgh, UK
• Professor D. Grahame Hardie, University of Dundee, UK
Speakers
• AMPK pharmacology and cancer
Professor D. Grahame Hardie, University of Dundee, UK
• Small molecule modulators of AMPK and diabetes
Dr Kei Sakamoto, Nestlé Institute of Health Sciences, Switzerland
• System Pharmacology of the AMPK-activated Protein Kinase
Dr Sandra Galic, St Vincent's Institute for Medical Research, Australia
• AMPK-dependent modulation of breathing and oxygen supply: an emerging therapeutic strategy for sleep apnoea and pulmonary hypertension?
Professor A. Mark Evans, University of Edinburgh, UK